Wolverine Trading
MCRB icon

Wolverine Trading’s Seres Therapeutics MCRB Stock Holding History

Wolverine Trading’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,107
Closed -$18K – 5637
2024
Q3 		$20.3K Sell
1,107
-148
-12% -$3K ﹤0.01% 4635
2024
Q2 		$18.2K Buy
1,255
+357
+40% +$5.96K ﹤0.01% 4338
2024
Q1 		$13.9K Buy
+898
New +$19.4K ﹤0.01% 4356
2023
Q3 		– Sell
-775
Closed -$59.1K – 4842
2023
Q2 		$72.7K Buy
775
+101
+15% +$11K ﹤0.01% 3859
2023
Q1 		$72K Buy
+674
New +$72.9K ﹤0.01% 3746
2021
Q3 		– Sell
-617
Closed -$121K – 6670
2021
Q2 		$295K Sell
617
-446
-42% -$188K ﹤0.01% 4441
2021
Q1 		$413K Buy
1,063
+607
+133% +$279K ﹤0.01% 4004
2020
Q4 		$239K Buy
+456
New +$267K ﹤0.01% 4020

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Wolverine Trading's MCRB Position: Q4 2024 in Review

Wolverine Trading sold out of Seres Therapeutics (MCRB) in Q4 2024, closing a stake of 1,107 shares — an estimated $18K sold.

Wolverine Trading first reported a position in MCRB in Q4 2020 and held it in 8 quarters. The position peaked at $413K in Q1 2021. 69 funds tracked by Wall St. Rank hold MCRB as of Q4 2024.

  • Wolverine Trading reported no remaining Seres Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Wolverine Trading sold 1,107 Seres Therapeutics shares in Q4 2024, an estimated $18K.
  • Wolverine Trading first reported a position in Seres Therapeutics in Q4 2020 and held it in 8 quarters.
  • Wolverine Trading's Seres Therapeutics position peaked at $413K in Q1 2021.
  • 69 funds tracked by Wall St. Rank held Seres Therapeutics as of Q4 2024.

Based on Wolverine Trading's 13F filing for Q4 2024, filed 14 Feb 2025.